Mesoblast Ltd - ADR

Mesoblast Ltd - ADR

MESO

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.25B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mesoblast Ltd - ADRMesoblast Ltd - ADR-23.3--10%-0.2
$39.00

Target Price by Analysts

125.2% upsideMesoblast Target Price DetailsTarget Price
$-4.94

Current Fair Value

128.5% downside

Overvalued by 128.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.25 Billion
Enterprise Value$2.27 Billion
Dividend Yield$- (-)
Earnings per Share$-0.45
Beta0.81
Outstanding Shares129,775,449

Return

Return on Equity-10.12%ROE
Return on Assets-7.44%
Return on Invested Capital-7.41%

Valuation & Multiples

P/E Ratio-23.3P/E Ratio
PEG34.26PEG
Price to Sales-Price to Sales
Price to Book Ratio4.33Price to Book Ratio
Enterprise Value to Revenue18.88
Enterprise Value to EBIT-44.31
Enterprise Value to Net Income-40
Total Debt to Enterprise0.06
Debt to Equity0.22Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 4, 2026
EPS Estimate
$-0.11
Average shareholder expectation
Revenue Estimate
$47.13 M
Average shareholder expectation

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
$-0.15
Average shareholder expectation
Revenue Estimate
$87.89 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1126 3.91%
Total Calls1,384,100 31.12%
Total Puts155,900 5.55%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.55% 0.69%
Total Invested$50.54M 32.93%
Investors Holding75 7.00%

ESG Score

No data

About Mesoblast Ltd

CEO: Silviu Itescu